Cargando…
Nebulized antithrombin limits bacterial outgrowth and lung injury in Streptococcus pneumoniae pneumonia in rats
INTRODUCTION: Disturbed alveolar fibrin turnover is a cardinal feature of severe pneumonia. Clinical studies suggest that natural inhibitors of coagulation exert lung-protective effects via anticoagulant and possibly also anti-inflammatory pathways. Intravenous infusion of the natural anticoagulants...
Autores principales: | Hofstra, Jorrit J, Cornet, Alexander D, de Rooy, Bart F, Vlaar, Alexander P, van der Poll, Tom, Levi, Marcel, Zaat, Sebastian AJ, Schultz, Marcus J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784363/ https://www.ncbi.nlm.nih.gov/pubmed/19740417 http://dx.doi.org/10.1186/cc8040 |
Ejemplares similares
-
Nebulized Fibrinolytic Agents Improve Pulmonary Fibrinolysis but Not Inflammation in Rat Models of Direct and Indirect Acute Lung Injury
por: Hofstra, Jorrit J., et al.
Publicado: (2013) -
Feasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae Pneumonia
por: van den Boogaard, Florry E., et al.
Publicado: (2015) -
Plasma-derived human antithrombin attenuates ventilator-induced coagulopathy in a Streptococcus pneumoniae pneumonia model in rats
por: Aslami, H, et al.
Publicado: (2009) -
Nebulized C1-Esterase Inhibitor does not Reduce Pulmonary Complement Activation in Rats with Severe Streptococcus
Pneumoniae Pneumonia
por: de Beer, Friso, et al.
Publicado: (2016) -
Nebulized heparin reduces levels of pulmonary coagulation activation in acute lung injury
por: Dixon, Barry, et al.
Publicado: (2010)